col blocks we are bridge builder col blocks
COVID Antworten in den wissenschaftlichen Zeitschriften der Welt


106 Ergebisse       Seite 1

 [1] 
Springer (Biomed Central Ltd.): Journal of Pharmaceutical Policy and Practice
  Original Artikel Datum Titel Autoren   Max. 6 Autoren
1 [GO] 2025―Aug―27 The impact of alternative care pathways adopted during the COVID-19 pandemic on the management of non-communicable diseases at a tertiary care hospital in Thailand Jongkonnee Chongpornchai, Tuangrat Phodha, Thanawat Wongphan, Kamonwan Soonklang, Peter C. Coyte
2 [GO] 2025―Jul―23 Prevalence, patterns, drivers, and perceived benefits of herbal medicine use in COVID-19 patients in Qatar Raneem Alsheikh, Fatima R. Alsharif, Nouran Alwisi, Zachariah Nazar, Mohamed Ahmed Syed, Hamda Abdulla Qotba, Layla Al-Mansoori, Zumin Shi, Abdullah A. Shaito
3 [GO] 2025―Feb―05 The prevalence of thromboembolic events among COVID-19 patients admitted to a single centre intensive care unit (ICU): an epidemiological study from a Malaysian population Nur Farhani Mansor, Izzati Abdul Halim Zaki, Lee Chew Kiok, Eng Kar Seng, Tharmini Ravi, Mohan Pathmanathan, Khang Wen Goh, Long Chiau Ming, Pakhrur Razi, Hanis Hanum Zulkifly
4 [GO] 2025―Jan―28 How does the medicines retail sector ensure continued access to medicines during public health emergencies? Lessons from the COVID-19 pandemic in Uganda Eleanor Hutchinson, Sunday Mundua, Jessica Myers, Sian E. Clarke, Kristian Schultz Hansen, Chrispus Mayora, Freddie Ssengooba, Freddy Eric Kitutu
5 [GO] 2024―Okt―29 A quantitative investigation in a territory of Italy on citizens’ attitudes towards medicines through the COVID-19 pandemic: the importance of possible indirect effects caused by the pandemic Antonio Mastino, Francesca Pettinau, Piergiorgio Palla, Giuseppina Ozzella, Massimiliano Grosso, Barbara Pittau
6 [GO] 2024―Sep―25 Trends in medicine utilisation in public and private healthcare facilities before and during COVID-19: a nationwide analysis of medicine procurement and sales data, 2018-2022 Norazida Ab Rahman, Ee Vien Low, Audrey Huili Lim, Azzy Iyzati Ahmad Shanizza, See Wan Ho, Mardhiyah Kamal, Abdul Haniff Mohamad Yahaya, Sheamini Sivasampu
7 [GO] 2024―Jul―12 The pharmacists’ interventions after a Drug and Therapeutics Committee (DTC) establishment during the COVID-19 pandemic Amira B. Kassem, Ahmad Z. Al Meslamani, Dina H. Elmaghraby, Yosr Magdy, Mohamed AbdElrahman, Ahmed M.E. Hamdan, Hebatallah Ahmed Mohamed Moustafa
8 [GO] 2024―Apr―17 Methylprednisolone use in hospitalised COVID-19 patients: a retrospective study Nur Fatin Najwa Azemi, Farida Islahudin, Rahela Ambaras Khan, Shamin Mohd Saffian, Leong Chee Loon
9 [GO] 2024―Mrz―14 Odds and associated factors for thrombosis development among Lebanese COVID-19 patients: a case-control retrospective study Mahmoud Youness, Sara Mansour, Fouad Sakr, Samer Olabi, Sarah Atwi, Iman Younes Martinez, Sami El Khatib, Souheil Hallit, Pascale Salameh, Diana Malaeb, Hassan Hosseini
10 [GO] 2024―Feb―27 Self-reported side effects of COVID-19 vaccines among the public Mahmathi Karuppannan, Long Chiau Ming, Mohd Shahezwan Abdul Wahab, Zakiah Mohd Noordin, Shermaine Yee, Andi Hermansyah
11 [GO] 2024―Jan―21 A qualitative study exploring community pharmacists’ awareness, attitudes and perceptions about drive-thru community pharmacy service in Malaysia during COVID-19 Bayan F. Ababneh, Siew Chin Ong, Iffat Elbarazi, Hisham Z. Aljamal, Rabia Hussain
12 [GO] 2024―Jan―03 Healthcare commissioners’ experience with antibiotic resistance during the COVID-19 pandemic in Saudi Arabia: a qualitative study Hadi Jaber Al Sulayyim, Rohani Ismail, Abdullah Al Hamid, Noraini Abdul Ghafar
13 [GO] 2024―Jan―03 Psychological dynamics of pandemic resilience: a tale of two cultures Shazia Rehman, Erum Rehman, Akhlaq Awan
14 [GO] 2023―Dez―21 Changes in prescribing of psychotropic vs some physical health medication in primary care through the COVID-19 pandemic in England: a national-level survey Unaiza Waheed, Mike Stedman, Mark Davies, Emma Solomon, David Taylor, Adrian Heald, Ram Prakash Narayanan, John Warner-Levy
15 [GO] 2023―Dez―11 Correction: mRNA vaccine development during the COVID-19 pandemic: a retrospective review from the perspective of the Swiss affiliate of a global biopharmaceutical company Tim Killeen, Vanessa Kermer, Rahel Troxler Saxer
16 [GO] 2023―Nov―28 Reliability and validity of the Malay version of the drive-thru community pharmacy service questionnaire and the Malaysian public’s awareness, attitudes, and perceptions of drive-thru community pharmacy during COVID-19 Bayan F. Ababneh, Siew Chin Ong, Louai Alsaloumi, Hisham Z. Aljamal, Rabia Hussain
17 [GO] 2023―Nov―28 Behaviour and associated determinants of COVID-19 vaccine acceptance and advocacy: a nationwide survey of pharmacy professionals in Qatar Moza Al Hail, Pallivalapila Abdulrouf, Derek Stewart, Wessam Elkassem, Rajvir Singh, Rasha Al Enany, Aftab Mohammed Azad, Asma Tarannum, Binny Thomas
18 [GO] 2023―Nov―27 mRNA vaccine development during the COVID-19 pandemic: a retrospective review from the perspective of the Swiss affiliate of a global biopharmaceutical company Tim Killeen, Vanessa Kermer, Rahel Troxler Saxer
19 [GO] 2023―Nov―27 Evaluation of outpatient prescription patterns of COVID-19 drugs in Iran: comparison of real practice with local therapeutic recommendations Amir H. Zargarzadeh, Zoha Abdi, Sarah Mousavi
20 [GO] 2023―Nov―20 Does tocilizumab have an effect on the clinical outcomes in COVID-19 patients? A meta-analysis of randomized control trials Faezeh Ghaempanah, Maziar Nikouei, Mojtaba Cheraghi, Arman Jahangiri, Yousef Moradi
21 [GO] 2023―Nov―13 Examining corruption risks in the procurement and distribution of COVID-19 vaccines in select states in Nigeria Obinna Onwujekwe, Charles Orjiakor, Pamela Ogbozor, Ifunanya Agu, Prince Agwu, Tom Wright, Dina Balabanova, Jillian Kohler
22 [GO] 2023―Okt―25 Medication management of COVID-19 patients during transition to virtual models of care: a qualitative study H. Laetitia Hattingh, Catherine Edmunds, Brigid M. Gillespie
23 [GO] 2023―Sep―22 Impact of COVID-19 on the supply chain of essential health commodities: a mixed method study, in Dar es Salaam, Tanzania Pius Ipagala, Eulambius M. Mlugu, Rogers Mwakalukwa, Godeliver A. Kagashe
24 [GO] 2023―Aug―10 A qualitative assessment of the adverse effects associated with COVID-19 vaccines: a study from Jordan Rawan Al-Bawab, Rana Abu-Farha, Faris El-Dahiyat, Razan I. Nassar, Mohammed Zawiah
25 [GO] 2023―Jul―10 Experience and attitudes of pharmacists towards challenges and adaptive measures to new norm in ward pharmacy practice during the COVID-19 pandemic Chew Beng Ng, You Leng Tan, Ros Sakinah Kamaludin, Chee Tao Chang, Chii-Chii Chew, Wai Keng Foong, Siew Huang Lee, Normi Hamdan, Su Yin Ong
26 [GO] 2023―Jun―13 Following the COVID-19 playbook and battling another infodemic: conspiracy beliefs around human monkeypox among the Lebanese population Dalal Youssef, Lea Bleibel, Edmond Abboud
27 [GO] 2023―Mai―17 The impact of COVID-19 on electronic repeat dispensing (eRD) in general practice Raman Sharma, Farideh A. Javid
28 [GO] 2023―Apr―05 Attitudes and concerns regarding booster dose of COVID-19 vaccine among Egyptian patients with autoimmune and rheumatic diseases: a cross-sectional survey study Samar Tharwat, Elshimaa Saad Eleraky, Toqa Adel, Mohammed Kamal Nassar, Marwa Saleh
29 [GO] 2023―Mrz―26 Qualitative exploration of perspectives of the pharmacists working in public-sector hospitals during COVID-19 pandemic Sitaram Khadka, Mohammad Saleem, Muhammad Usman, Furqan K. Hashmi, Fatima Tariq, Warda Zaheer, Sabahat Imon, Aqsa Inam, Ravi Prasad Gupta, Pallav Aryal
30 [GO] 2023―Mrz―22 Continuity of CVD treatment during the COVID-19 pandemic: evidence from East Java, Indonesia Aksari Dewi, Elizabeth Pisani, Bachtiar Rifai Pratita Ihsan, Ayuk Lawuningtyas Hariadini, Anushka Patel, Anna Palagyi, Devarsetty Praveen, Diana Lyrawati
31 [GO] 2023―Mrz―09 COVID-19 and diabetes in 2020: a systematic review Farideh A. Javid, Fadi Abdul Waheed, Nisa Zainab, Hamza Khan, Ibrahim Amin, Ammar Bham, Mohammed Ghoghawala, Aneem Sheraz, Radi Haloub
32 [GO] 2023―Mrz―03 Secondary bacterial infection caused by ST16 NDM-1 and OXA-48-producing colistin and carbapenem-resistant Klebsiella pneumoniae treated with tigecycline in a pregnant woman with COVID-19 Samaneh Pourajam, Azam Zafarbakhsh, Majid Hosseinzadeh, Mohammad Shirzadi, Mansour Siavash, Hamid Solgi
33 [GO] 2023―Mrz―02 Impact of COVID-19 pandemic on the availability of maternal and child health products and childhood vaccines Tsegaye Melaku, Desta Assefa, Fanta Gashe, Mestawet Getachew, Temesgen Kabeta, Zeleke Mekonnen
34 [GO] 2023―Mrz―02 Hospital pharmacy response to the COVID-19 pandemic: experience from a regional referral center in the United Arab Emirates Muhammad Hammad, Mohammad Mousa Tashtoush, El Mutasim Ahmed El Faki, Marwa Yousif Hajaj, Saima Saeed Ahmed, Amal Ahmed Darwish
35 [GO] 2023―Feb―24 Telepharmacy during home isolation: drug-related problems and pharmaceutical care in COVID-19 patients receiving antiviral therapy in Thailand Worapong Sungsana, Chotirat Nakaranurack, Benjabhorn Weeraphon, Watsa Charoenwaiyachet, Supparat Chanprasert, Pattama Torvorapanit, Wichai Santimaleeworagun, Opass Putcharoen
36 [GO] 2023―Feb―24 A 1-year analysis of adverse events following COVID-19 vaccination in Lebanon: a retrospective study Abeer Zeitoun, Souheil Hallit, Sirine Chehade, Aya Ibrahim, Maya Helali, Carla Allam, Rita Karam
37 [GO] 2023―Jan―27 Community pharmacists’ perceptions and experiences of stress during COVID-19 Loreta Tobia, Mario Muselli, Fabio De Luca, Vincenza Cofini, Giada Mastrangeli, Leila Fabiani, Stefano Necozione
38 [GO] 2023―Jan―17 Leveraging electronic logistics management information systems to enhance and optimize supply chain response during public health emergencies: lessons from COVID-19 response in Uganda John Hans Wasswa, Henry Oundo, Martin Olowo Oteba, Henry Komakech, Irene Ochola, Sheila Mwebaze, Denis Okidi, Anthony Kirunda, Shamim Nakadde, Neville Okuna Oteba, Eric Lugada
39 [GO] 2023―Jan―16 Effectiveness of different treatment regimens on patients with COVID-19, hospitalized in Sanandaj hospitals: a retrospective cohort study Jalal Asadi, Mohammad Aziz Rasouli, Ebrahim Ghaderi, Daem Roshani, Behzad Mohsenpour, Yousef Moradi, Ghobad Moradi
40 [GO] 2023―Jan―12 Polypharmacy and potentially inappropriate medications among hospitalized older adults with COVID-19 in Malaysian tertiary hospitals Chee-Tao Chang, Siti Mallissa Mohd Shariff, Nur Suriana Abu Bakar, Nasiha Sufina Ramzuzzaman, Chun Kiat Lim, Eddy Yew Joe Lim, Peng Seng Ong, Jie Min Lee, Aie Yen Tan, Siti Fatimah Kamis, Wei Mun Liew, Yuet Man Low, Doris George, James Yau Hon Voo, Hoo Seng Tan, Philip Rajan, Shaun Wen Huey Lee
41 [GO] 2022―Dez―16 Prevalence and correlates of burnout among Lebanese health care workers during the COVID-19 pandemic: a national cross-sectional survey Dalal Youssef, Edmond Abboud, Linda Abou-Abbas, Hamad Hassan, Janet Youssef
42 [GO] 2022―Nov―23 Changes in drug demand when a pandemic coincides with other outbreaks in a war zone country: a cross-sectional pilot study Ebtesam A. Saleh, Randa N. Haddadin, Bassam Saleh, Eman Elayeh
43 [GO] 2022―Nov―04 The effect of COVID-19 home quarantine on the psychological state of pharmacy students: a cross-sectional study Asmaa S. Mohamed, Ahmed A. Abdelrahman, Hosam M. Ahmad, Omar R. Abdel Aziz, Yasmeen S. Mesameh, Soad A. Mohamad
44 [GO] 2022―Okt―30 Public views of community pharmacy services during the COVID-19 pandemic: a national survey Alein W. Bou-Saba, Kassem M. Kassak, Pascale R. Salameh
45 [GO] 2022―Okt―23 Managing nirmatrelvir/ritonavir during COVID-19: pharmacists’ experiences from the Perak state of Malaysia Chee Tao Chang, Su Yin Ong, Xin Jie Lim, Lan Sim Chew, Philip Rajan
46 [GO] 2022―Okt―18 Mental health outcomes and workplace quality of life among South African pharmacists during the COVID-19 pandemic: a cross-sectional study Sherishka Dhindayal, Marothi P. Letsoalo, Tanuja N. Gengiah
47 [GO] 2022―Okt―15 Vaccination process evaluation at COVID-19 vaccination centers in Lebanon: a national study Abeer Zeitoun, Souheil Hallit, Maya Helali, Sirine Chehade, Carla Allam, Aya Ibrahim, Hani Dimassi, Rita Karam
48 [GO] 2022―Okt―06 Parental COVID-19 vaccination hesitancy among parents of children aged 5-18 years in Thailand: a cross-sectional survey study Pantira Parinyarux, Kanokkarn Sunkonkit, Kitiyot Yotsombut
49 [GO] 2022―Aug―30 Practice of non-pharmaceutical interventions against COVID-19 and reduction of the risk of influenza-like illness: a cross-sectional population-based study Dalal Youssef, Ola Issa, Maysaloun Kanso, Janet Youssef, Linda Abou-Abbas, Edmond Abboud
50 [GO] 2022―Aug―19 State capture through indemnification demands? Effects on equity in the global distribution of COVID-19 vaccines Ariel Gorodensky, Jillian C. Kohler
51 [GO] 2022―Aug―17 An analysis of COVID-19 information sources Belachew Umeta, Temesgen Mulugeta, Girma Mamo, Sintayehu Alemu, Nimona Berhanu, Gudina Milkessa, Birhanu Mengistu, Tsegaye Melaku
52 [GO] 2022―Jul―29 The need for a functional pharmaceutical industry in Sierra Leone: lessons from the COVID-19 pandemic Eugene Conteh, Melody Okereke, Foday Umaro Turay, Alhaji Sununu Bah, Abdulwasiu Muhsinah
53 [GO] 2022―Jun―16 Contributions and challenges of community pharmacists during the COVID-19 pandemic: a qualitative study Claire Durand, Eric Douriez, Aude Chappuis, Frédérique Poulain, Yazdan Yazdanpanah, Sylvie Lariven, François-Xavier Lescure, Nathan Peiffer-Smadja
54 [GO] 2022―Mai―02 Prevalence, pattern and predictors of self-medication for COVID-19 among residents in Umuahia, Abia State, Southeast Nigeria: policy and public health implications Chidinma Ihuoma Amuzie, Kalu Ulu Kalu, Michael Izuka, Uche Ngozi Nwamoh, Uloaku Emma-Ukaegbu, Franklin Odini, Kingsley Metu, Chigozie Ozurumba, Ijeoma Nkem Okedo-Alex
55 [GO] 2022―Apr―26 COVID-19 vaccines: awareness, attitude and acceptance among undergraduate University students Firew Asres, Belachew Umeta
56 [GO] 2022―Apr―01 Redistribution of critical drugs in shortage during the first wave of COVID-19 in France: from operating theaters to intensive care units Claire Chapuis, Rémy Collomp, Laura Albaladejo, Hugo Terrisse, Stéphane Honoré, Jean-Luc Bosson, Pierrick Bedouch, Pierre Albaladejo
57 [GO] 2022―Mrz―28 Assessing public knowledge, attitudes and determinants of third COVID-19 vaccine booster dose acceptance: current scenario and future perspectives Ammar Abdulrahman Jairoun, Sabaa Saleh Al-Hemyari, Faris El-Dahiyat, Maimona Jairoun, Moyad Shahwan, Mena Al Ani, Mustafa Habeb, Zaheer-Ud-Din Babar
58 [GO] 2022―Mrz―17 Feeling the burn in the era of COVID-19: cross-cultural adaptation and validation of the Arabic version of the Copenhagen Burnout Inventory among community pharmacists Dalal Youssef, Linda Abou-Abbas, Janet Youssef
59 [GO] 2022―Mrz―02 Management of COVID-19 vaccines cold chain logistics: a scoping review Mathumalar Loganathan Fahrni, Intan An-Nisaa’ Ismail, Dalia Mohammed Refi, Ahmad Almeman, Norliana Che Yaakob, Kamaliah Md Saman, Nur Farhani Mansor, Noorasmah Noordin, Zaheer-Ud-Din Babar
60 [GO] 2022―Jan―11 The landscape of antibiotic usage among COVID-19 patients in the early phase of pandemic: a Malaysian national perspective Izzati-Nadhirah Mohamad, Calvin Ke-Wen Wong, Chii-Chii Chew, E-Li Leong, Biing-Horng Lee, Cheng-Keat Moh, Komalah Chenasammy, Steven Chee-Loon Lim, Hong-Bee Ker
61 [GO] 2022―Jan―11 Assessment of COVID-19 vaccines acceptance in the Lebanese population: a national cross-sectional study Philippe Hanna, Aline Issa, Ziad Noujeim, Mira Hleyhel, Nadine Saleh
62 [GO] 2021―Dez―24 Prevalence and risk factors of burnout among Lebanese community pharmacists in the era of COVID-19 pandemic: results from the first national cross-sectional survey Dalal Youssef, Janet Youssef, Hamad Hassan, Linda Abou-Abbas
63 [GO] 2021―Dez―24 Marketing authorization of COVID-19 vaccines across UK, EU, and the US: fact-checking and the implications for future research Nasir Abbas, Zaheer-Ud-Din Babar
64 [GO] 2021―Dez―02 Knowledge and perceptions of pharmacists’ readiness during coronavirus pandemic: the case of United Arab Emirates Iman A. Basheti, Nizar M. Mhaidat, Sayer Al-Azzam, Rajaa Alqudah, Razan Nassar, Hamzah Alzubaidi, Mahmoud S. Abu-Samak, Eman Abu-Gharbieh
65 [GO] 2021―Nov―04 COVID-19’s impact on neglected pharmaceutical staff: wake-up call for needed research Richard Antony Powell, Shivali Lakhani, Marsha Alter, Steven Guan, Jehanita Jesuthasan, Dasha Nicholls
66 [GO] 2021―Okt―25 Incidence of adverse reaction of drugs used in COVID-19 management: a retrospective, observational study Jia Yin Lee, Abby Shoon Yeun Ang, Nurdalila Mohd Ali, Li Min Ang, Azura Omar
67 [GO] 2021―Sep―29 Impact of the first phase of COVID-19 pandemic on childhood routine immunisation services in Nepal: a qualitative study on the perspectives of service providers and users Asmita Priyadarshini Khatiwada, Smriti Maskey, Nistha Shrestha, Sunil Shrestha, Saval Khanal, Bhuvan KC, Vibhu Paudyal
68 [GO] 2021―Aug―06 Young hospital pharmacists’ job stress and career prospects amidst the COVID-19 pandemic in China Jiahao Wu, Jian Cai, Ming Fang, Yan Wang, Feng Xu
69 [GO] 2021―Jul―18 Pharmacy preparedness in handling COVID-19 pandemic: a sharing experience from a Malaysian tertiary hospital Kah Shuen Thong, Manimegahlai Selvaratanam, Chiew Ping Tan, Meng Fei Cheah, Hoey Lin Oh, Pooi Mun Lee, Chii-Chii Chew, Chee-Tao Chang, Jason Choong Yin Lee
70 [GO] 2021―Jun―11 A cross-sectional survey on community pharmacists readiness to fight COVID-19 in a developing country: knowledge, attitude, and practice in Lebanon Rony M. Zeenny, Ahmad Dimassi, Hala Sacre, Ghada El Khoury, Aline Hajj, Rita Farah, Hind Hajj, Nathalie Lahoud, Marwan Akel, Souheil Hallit, Pascale Salameh
71 [GO] 2021―Mai―11 Correction to: Online medication purchasing during the Covid-19 pandemic: a pilot study from the United Arab Emirates Ammar Abdulrahman Jairoun, Sabaa Saleh Al-Hemyari, Naseem Mohammed Abdulla, Faris El-Dahiyat, Maimona Jairoun, Saleh Karamah AL-Tamimi, Zaheer-Ud-Din Babar
72 [GO] 2021―Mai―10 Assessments of the quality systems of pharmaceutical distributors: a remote approach to be applied in times of COVID-19 and beyond Anthony Bourasseau, Laurine Lavergne, Raffaella Ravinetto
73 [GO] 2021―Mai―03 Public and private sectors collective response to combat COVID-19 in Malaysia Ching Siang Tan, Saim Lokman, Yao Rao, Szu Hua Kok, Long Chiau Ming
74 [GO] 2021―Mai―03 Adequacy of alcohol-based handrub solution production practice in response to COVID-19 in public hospitals found in Addis Ababa, Ethiopia: a multicentered cross-sectional study Muluken Nigatu Selam, Regasa Bayisa, Andualem Ababu, Mahdi Abdella, Edessa Diriba, Minychel Wale, Assefa Mulu Baye
75 [GO] 2021―Apr―30 Online medication purchasing during the Covid-19 pandemic: potential risks to patient safety and the urgent need to develop more rigorous controls for purchasing online medications, a pilot study from the United Arab Emirates Ammar Abdulrahman Jairoun, Sabaa Saleh Al-Hemyari, Naseem Mohammed Abdulla, Faris El-Dahiyat, Maimona Jairoun, Saleh Karamah AL-Tamimi, Zaheer-Ud-Din Babar
76 [GO] 2021―Feb―24 Perceived barriers and facilitators to uptake of non-traditional roles by pharmacists in Saudi Arabia and implications for COVID-19 pandemic and beyond: a qualitative study using Theoretical Domain Framework Eeman Mohammed, Saval Khanal, Zahraa Jalal, Ejaz Cheema, Mohammed H. Abutaleb, Vibhu Paudyal
77 [GO] 2021―Feb―10 Universal health coverage and COVID-19: recent developments and implications Rabia Hussain, Sara Arif
78 [GO] 2021―Jan―22 Drug supply shortage in Nigeria during COVID-19: efforts and challenges Edward Faiva, Hashim Talib Hashim, Mustafa Ahmed Ramadhan, Shingin Kovona Musa, John Bchara, Yahya Dheyaa Tuama, Yusuff Adebayo Adebisi, Mustafa Hayder Kadhim, Mohammad Yasir Essar, Shoaib Ahmad, Don Eliseo Lucero-Prisno
79 [GO] 2021―Jan―20 Drug supply situation in Rwanda during COVID-19: issues, efforts and challenges Theogene Uwizeyimana, Hashim Talib Hashim, Jean Damascene Kabakambira, Jean Claude Mujyarugamba, Jackson Dushime, Blaise Ntacyabukura, Remy Ndayizeye, Yusuff Adebayo Adebisi, Don Eliseo Lucero-Prisno
80 [GO] 2021―Jan―06 New missions of a hospital pharmaceutical technology unit during the COVID-19 pandemic Alexandra Garnier, Ludivine Falaschi, Pascal Bonnabry, Lucie Bouchoud
81 [GO] 2021―Jan―04 Medicines dispensing practice during the era of COVID-19 pandemic: a commentary Gemmechu Hasen, Rashed Edris, Gadisa Chala, Yesuneh Tefera, Hawi Hussen, Tamirat Tekassa, Sultan Suleman
82 [GO] 2020―Dez―09 Pharmacy response to COVID-19: lessons learnt from Canada Ali Elbeddini, Amy Botross, Rachel Gerochi, Mohamed Gazarin, Ahmed Elshahawi
83 [GO] 2020―Nov―02 Pharmacy services during COVID-19 pandemic: experience from a tertiary care teaching hospital in Pakistan Kashif Hussain, Gul Ambreen, Mehreen Muzammil, Syed Shamim Raza, Umer Ali
84 [GO] 2020―Okt―21 Needs assessment and impact of COVID-19 on pharmacy professionals in 31 commonwealth countries Diane Ashiru-Oredope, Amy Hai Yan Chan, Omotayo Olaoye, Victoria Rutter, Zaheer-Ud-Din Babar
85 [GO] 2020―Sep―22 Pharmacists’ perceived barriers towards delivering their emergency roles during the COVID-19 pandemic and perceived policymakers’ responsibilities Iman A. Basheti, Razan Nassar, Muna Barakat, Rajaa Alqudah, Rana Abu Farha, Tareq Muqatash, Samar Thiab, Bandana Saini
86 [GO] 2020―Sep―21 Understanding the factors influencing healthcare providers’ burnout during the outbreak of COVID-19 in Jordanian hospitals Abdullah Algunmeeyn, Faris El-Dahiyat, Mohammad Mitib Altakhineh, Mohammad Azab, Zaheer-Ud-Din Babar
87 [GO] 2020―Sep―21 The use of remdesivir outside of clinical trials during the COVID-19 pandemic Vesa Halimi, Armond Daci, Nevenka Ridova, Irina Panovska-Stavridis, Milena Stevanovic, Venko Filipce, Aleksandar Dimovski, Aleksandra Grozdanova
88 [GO] 2020―Sep―17 Assessing knowledge, attitude, practice, and preparedness of hospital pharmacists in Lebanon towards COVID-19 pandemic: a cross-sectional study Rony M. Zeenny, Elsy Ramia, Youssef Akiki, Souheil Hallit, Pascale Salameh
89 [GO] 2020―Sep―11 The Urgent Need for Transparent and Accountable Procurement of Medicine and Medical Supplies in Times of COVID-19 Pandemic Jillian Clare Kohler, Tom Wright
90 [GO] 2020―Jul―24 COVID-19 therapeutics: how to sow confusion and break public trust during international public health emergencies Jerome Amir Singh, Rafaella Ravinetto
91 [GO] 2020―Jul―22 Mental health issues impacting pharmacists during COVID-19 Ali Elbeddini, Cindy Xin Wen, Yasamin Tayefehchamani, Anthony To
92 [GO] 2020―Jul―17 Unrealized potential of drug repositioning in europe during COVID-19 and beyond: a physcian’s perspective A. B. Bayoumy, N. K. H. de Boer, A. R. Ansari, F. Crouwel, C. J. J. Mulder
93 [GO] 2020―Jul―15 Risks to the community pharmacists and pharmacy personnel during COVID-19 pandemic: perspectives from a low-income country B. Dzingirai, C. M. J. Matyanga, T. Mudzviti, M. Siyawamwaya, D. Tagwireyi
94 [GO] 2020―Jul―15 Identification of the awareness level by the public of Arab countries toward COVID-19: cross-sectional study following an outbreak Ruwidah Bonyan, Aseel Fuad Al-Karasneh, Faris El-Dahiyat, Ammar Abdulrahman Jairoun
95 [GO] 2020―Jul―11 Saudi Arabia, pharmacists and COVID-19 pandemic Ajaz Ahmad, Khalid M. Alkharfy, Ziyad Alrabiah, Abdulaziz Alhossan
96 [GO] 2020―Jun―19 Pharmacists and COVID-19 Ali Elbeddini, Thulasika Prabaharan, Sarah Almasalkhi, Cindy Tran
97 [GO] 2020―Jun―15 COVID-19 and community pharmacy services in Pakistan: challenges, barriers and solution for progress Muhammad Atif, Iram Malik
98 [GO] 2020―Jun―11 Correction to: Amid COVID-19: the importance of developing an positive adverse drug reaction (ADR) and medical device incident (MDI) reporting culture for Global Health and public safety Ali Elbeddini, Aniko Yeats, Stephanie Lee
99 [GO] 2020―Mai―27 Pharmacist intervention amid the coronavirus disease 2019 (COVID-19) pandemic: from direct patient care to telemedicine Ali Elbeddini, Aniko Yeats
100 [GO] 2020―Mai―25 Pharmacists reinventing their roles to effectively respond to COVID-19: a global report from the international pharmacists for anticoagulation care taskforce (iPACT) Filipa Alves da Costa, Vivian Lee, Silvana Nair Leite, Maria Dolores Murillo, Tom Menge, Sotiris Antoniou
101 [GO] 2020―Mai―20 Sterilization plan of the used metered dose inhalers (MDI) to avoid wastage amid COVID-19 pandemic drug shortage Ali Elbeddini
102 [GO] 2020―Mai―18 Amid COVID-19: the importance of developing an positive adverse drug reaction (ADR) and medical device incident (MDI) reporting culture for Global Health and public safety Ali Elbeddini, Aniko Yeats, Stephanie Lee
103 [GO] 2020―Mai―16 Current regulatory approaches for accessing potential COVID-19 therapies Vesa Halimi, Armond Daci, Simona Stojanovska, Irina Panovska-Stavridis, Milena Stevanovic, Venko Filipce, Aleksandra Grozdanova
104 [GO] 2020―Mai―15 A step towards gender equity to strengthen the pharmaceutical workforce during COVID-19 Nadia Bukhari, Mehr Manzoor, Huma Rasheed, Bismah Nayyer, Madeeha Malik, Zaheer-Ud-Din Babar
105 [GO] 2020―Mai―13 Together we unite: the role of the Commonwealth in achieving universal health coverage through pharmaceutical care amidst the COVID-19 pandemic Amy Hai Yan Chan, Victoria Rutter, Diane Ashiru-Oredope, Chloe Tuck, Zaheer-Ud-Din Babar
106 [GO] 2020―Apr―20 Pharmacists at the frontline beating the COVID-19 pandemic Nadia Bukhari, Huma Rasheed, Bismah Nayyer, Zaheer-Ud-Din Babar
 [1] 

106 Ergebisse       Seite 1



[de][en]

Letzte Änderung 2025―Jul―29 14:55:09 UTC

© Daten-Quadrat 2022       Done in 0.004 sec